Guillain–Barre syndrome (GBS) is an acute-onset immune-mediated polyneuropathy characterized by ascending symmetrical muscle weakness, diminished reflexes, and sensory symptoms. While GBS typically follows a monophasic course, some patients …

Guillain–Barré syndrome (GBS), which is an acute immune-mediated peripheral neuropathy, is mainly triggered by preceding respiratory or gastrointestinal tract infections [ 1 ]. The incidence of GBS is 0.81 to 1.89 cases per 100, 000 person-years …

Guillain–Barré syndrome (GBS) is an immune-mediated polyneuropathy, with an annual global incidence of approximately 100,000 cases [ 1 ]. It typically presents as a monophasic disease marked by progressive flaccid paralysis. GBS is caused by …

Immer wieder wurden Fälle von Guillain-Barré-Syndrom (GBS) geschildert, die mit einer Coronaimpfung zusammenhängen. Eine neue Studie zeigt jedoch: Eine mRNA-Impfung scheint das Risiko eher zu senken, eine Infektion hingegen zu erhöhen. © …

Guillian-Barré syndrome (GBS) is a post-infectious autoimmune polyradiculopathy affecting the peripheral nerves and occasionally cranial nerves, resulting in an acute onset, ascending flaccid paralysis. Since it was first described by Guillian and …

Guillain–Barré syndrome (GBS) is an immune-mediated condition that affects either the myelin sheath or the axons of the peripheral nerves. It has protean manifestations but commonly, it presents with symmetrical and monophasic acute flaccid …

Landry-Guillain-Barré syndrome (LGBS) is an acute self-limited polyneuropathy named after Guillain, Barre and Strohl, who first of all reported it in 1916 [ 1 , 2 ]. LGBS is the most common cause of acute flaccid paralysis in both the developed and …

Guillain–Barré syndrome (GBS) is an immune-mediated peripheral neuropathy characterized by a variable clinical course and outcome. Its prototype form develops in susceptible individuals following infections or, more rarely, vaccines [ 1 ]. In the …